SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001047469-16-016310
Filing Date
2016-10-26
Accepted
2016-10-26 16:32:30
Documents
17

Document Format Files

Seq Description Document Type Size
1 F-1/A a2229218zf-1a.htm F-1/A 5461054
2 EX-23.1 a2229218zex-23_1.htm EX-23.1 4171
3 EX-23.2 a2229218zex-23_2.htm EX-23.2 3244
4 EX-24.2 a2229218zex-24_2.htm EX-24.2 4287
5 G509602.JPG g509602.jpg GRAPHIC 10987
6 G931859.JPG g931859.jpg GRAPHIC 72494
7 G392160.JPG g392160.jpg GRAPHIC 30678
8 G51153.JPG g51153.jpg GRAPHIC 65003
9 G30898.JPG g30898.jpg GRAPHIC 23853
10 G117215.JPG g117215.jpg GRAPHIC 25645
11 G894461.JPG g894461.jpg GRAPHIC 88193
12 G868172.JPG g868172.jpg GRAPHIC 35771
13 G147310.JPG g147310.jpg GRAPHIC 63183
14 G631018.JPG g631018.jpg GRAPHIC 86181
15 G428666.JPG g428666.jpg GRAPHIC 56321
16 G459984.JPG g459984.jpg GRAPHIC 40365
17 G64226.JPG g64226.jpg GRAPHIC 37122
  Complete submission text file 0001047469-16-016310.txt   6350357
Mailing Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000
Business Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000 34918060946
TiGenix NV (Filer) CIK: 0001581987 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9
Type: F-1/A | Act: 33 | File No.: 333-208693 | Film No.: 161952945
SIC: 2834 Pharmaceutical Preparations